Advances in Psychiatry

Home to the country’s top psychiatrists who are leading the field in patient care, research, and medical education.

Last year, we provided care for 20,000 patients and trained 100 residents. Our academic partners — Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons — are consistently ranked No. 1 in NIH funding. With nationally recognized psychiatrists and psychologists across two academic medical center campuses, we can offer robust specialized programs, such as Addiction & Substance Use Rehabilitation, Geriatric Psychiatry, and Ketamine therapy, to respond to our community’s needs.

image of cadb westchester building

Stephen Kanne, PhD Brings Innovative Approaches to Autism Care at CADB

Spearheaded by Stephen M. Kanne, PhD, the Center for Autism and the Developing Brain blends world-class psychiatry and autism expertise to bring the latest evidence-based approaches to the diagnosis and treatment of ASD.

image of Dr. Jonathan Avery

Online Databases: A Prescription for the Opioid Epidemic

As drug overdoses continue to rise in the United States, doctors and policymakers search for solutions to stem the tide of opioid-related deaths. Researchers at NewYork-Presbyterian/Weill Cornell are studying the efficacy of statewide online databases to track prescriptions.

image of Dr. Mark Olfson

Opioid Overdose Survivors Face Higher Death Rate

Researchers at NewYork-Presbyterian/Columbia have found opioid overdose survivors are at great risk of dying from respiratory diseases, viral hepatitis, and suicide in the year after an overdose, according to a report published in JAMA Psychiatry.

image of anxiety cells

‘Anxiety Cells’ Identified in the Brain’s Hippocampus

Neuroscientists at Columbia University Medical Center and the University of California, San Francisco, have found in mice that certain brain cells in the hippocampus fire when the animal is anxious, triggering anxiety-related behaviors.

image of Dr. J. John Mann

The Role of Ketamine in Treatment-Resistant Depression

It is estimated that by 2030 depressive illness will account for more disability than any other illness worldwide. Investigators at NewYork-Presbyterian/Columbia are studying the use of ketamine as a treatment option for reducing suicidal thoughts in patients with refractory depression.

image of Dr. Conor Liston

Defining Unique Subtypes in Depression

In a quest to better define depression diagnosis, a neuroscientist and psychiatrist at NewYork-Presbyterian/Weill Cornell used fMRI brain scans to identify unique subtypes of depression. The study may help physicians to better diagnose depression subtypes and determine which patients would benefit from TMS.

Newsletters for Medical Professionals

2021 Issue 2

2021 Issue 1

2020 Issue 1

2019 Issue 1

2018 Issue 3

2018 Issue 2

2018 Issue 1

2017 Issue 2

2017 Issue 1

2016 Issue 3

Spring 2016

Winter 2016

Spring 2015

November/December 2014

June/July 2014

January 2014

October/November 2013

February 2013

January 2013